The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Trends in mesenchymal stem cell clinical trials 2004-2018: Is efficacy optimal in a narrow dose range?
Open accessAbstract
The number of clinical trials using mesenchymal stem cells (MSCs) has increased since 2008, but this trend slowed in the past several years and dropped precipitously in 2018. Previous reports have analyzed MSC clinical trials by disease, phase, cell source, country of origin, and trial initiation date, all of which can be downloaded directly from ClinicalTrials.gov. We have extended analyses to a larger group of 914 MSC trials reported through 2018. To search for potential factors that may influence the design of new trials, we extracted data on routes of administration and dosing from individual ClinicalTrials.gov records as this information cannot be downloaded directly from the database. Intravenous (IV) injection is the most common, least invasive and most reproducible method, accounting for 43% of all trials. The median dose for IV delivery is 100 million MSCs/patient/dose. Analysis of all trials using IV injection that reported positive outcomes indicated minimal effective doses (MEDs) ranging from 70 to 190 million MSCs/patient/dose in 14/16 trials with the other two trials administering much higher doses of at least 900 million cells. Dose-response data showing differential efficacy for improved outcomes were reported in only four trials, which indicated a narrower MED range of 100-150 million MSCs/patient with lower and higher IV doses being less effective. The results suggest that it may be critical to determine MEDs in early trials before proceeding with large clinical trials. Lessons learned Initially, the number of trials increased, then leveled off several years ago and dropped dramatically in 2018. Many of the doses of cells being delivered may not be maximally effective because they are too low or high in some trials. It is important to test for efficacy as well as safety in early trials. Significance statementThe significance of this study is that critical numbers of cells may need to be used for the most effective stem cell therapies. The results suggest a range of minimally effective cell doses for intravenous injection, which is the method used in almost half of all therapies. Increasing doses are usually tested for safety, and the highest tolerated dose is often used in a clinical trial. Studies need to measure initial efficacy along with safety to use the most effective doses rather than the safest doses tolerated, which might be an overdose. Too many or few cells are not optimal.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lee, R. H., Pulin, A. A., Seo, M. J., Kota, D. J., Ylostalo, J., Larson, B. L., Semprun-Prieto, L., Delafontaine, P., & Prockop, D. J. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.05.003 · Cited by 1,898
Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities
Galipeau, J., & Sensébé, L. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.05.004 · Cited by 1,819
Osteogenesis in transplants of bone marrow cells
Friedenstein, A. J., Piatetzky-Shapiro, I. I., & Petrakova, K. V. (1966) · Development · doi:10.1242/dev.16.3.381 · Cited by 1,671
Clinical Trials with Mesenchymal Stem Cells: An Update
Squillaro, T., Peluso, G., & Galderisi, U. (2016) · Cell Transplantation · doi:10.3727/096368915x689622 · Cited by 1,395
Fischer, U. M., Harting, M. T., Jimenez, F., Monzon-Posadas, W. O., Xue, H., Savitz, S. I., Laine, G. A., & Cox, C. S. (2009) · Stem Cells and Development · doi:10.1089/scd.2008.0253 · Cited by 1,292
Why are MSCs therapeutic? New data: new insight
Caplan, A. (2009) · The Journal of Pathology · doi:10.1002/path.2469 · Cited by 1,114
Panés, J., García-Olmo, D., Van Assche, G., Colombel, J. F., Reinisch, W., Baumgart, D. C., Dignass, A., Nachury, M., Ferrante, M., Kazemi-Shirazi, L., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31203-x · Cited by 1,092
Mesenchymal stem cells: a new trend for cell therapy
Wei, X., Yang, X., Han, Z.-P., Qu, F.-F., Shao, L., & Shi, Y.-F. (2013) · Acta Pharmacologica Sinica · doi:10.1038/aps.2013.50 · Cited by 942
Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis
Gonzalez-Rey, E., Anderson, P., González, M. A., Rico, L., Büscher, D., & Delgado, M. (2009) · Gut · doi:10.1136/gut.2008.168534 · Cited by 677
Connick, P., Kolappan, M., Crawley, C., Webber, D. J., Patani, R., Michell, A. W., Du, M.-Q., Luan, S.-L., Altmann, D. R., Thompson, A. J., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70305-2 · Cited by 607
Tan, J., Wu, W., Xu, X., Liao, L., Zheng, F., Messinger, S., Sun, X., Chen, J., Yang, S., Cai, J., et al. (2012) · JAMA · doi:10.1001/jama.2012.316 · Cited by 553
Galipeau, J., Krampera, M., Barrett, J., Dazzi, F., Deans, R. J., DeBruijn, J., Dominici, M., Fibbe, W. E., Gee, A. P., Gimble, J. M., et al. (2016) · Cytotherapy · doi:10.1016/j.jcyt.2015.11.008 · Cited by 520
A Placebo-Controlled, Randomized Trial of Mesenchymal Stem Cells in COPD
Weiss, D. J., Casaburi, R., Flannery, R., LeRoux-Williams, M., & Tashkin, D. P. (2013) · Chest · doi:10.1378/chest.12-2094 · Cited by 423
Vangsness, C. T., Farr, J., Boyd, J., Dellaero, D. T., Mills, C. R., & LeRoux-Williams, M. (2014) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.m.00058 · Cited by 409
Biodistribution, migration and homing of systemically applied mesenchymal stem/stromal cells
Leibacher, J., & Henschler, R. (2016) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0271-2 · Cited by 367
Hess, D. C., Wechsler, L. R., Clark, W. M., Savitz, S. I., Ford, G. A., Chiu, D., Yavagal, D. R., Uchino, K., Liebeskind, D. S., Auchus, A. P., et al. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30046-7 · Cited by 367
Forbes, G. M., Sturm, M. J., Leong, R. W., Sparrow, M. P., Segarajasingam, D., Cummins, A. G., Phillips, M., & Herrmann, R. P. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.06.021 · Cited by 333
Lamo-Espinosa, J. M., Mora, G., Blanco, J. F., Granero-Moltó, F., Nuñez-Córdoba, J. M., Sánchez-Echenique, C., Bondía, J. M., Aquerreta, J. D., Andreu, E. J., Ornilla, E., et al. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-0998-2 · Cited by 329
Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjögren syndrome
Xu, J., Wang, D., Liu, D., Fan, Z., Zhang, H., Liu, O., Ding, G., Gao, R., Zhang, C., Ding, Y., et al. (2012) · Blood · doi:10.1182/blood-2011-11-391144 · Cited by 315
Preserved β-Cell Function in Type 1 Diabetes by Mesenchymal Stromal Cells
Carlsson, P.-O., Schwarcz, E., Korsgren, O., & Le Blanc, K. (2015) · Diabetes · doi:10.2337/db14-0656 · Cited by 315
Mesenchymal stem cells: mechanisms of potential therapeutic benefit in ARDS and sepsis
Walter, J., Ware, L. B., & Matthay, M. A. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70217-6 · Cited by 278
Jo, C. H., Chai, J. W., Jeong, E. C., Oh, S., Shin, J. S., Shim, H., & Yoon, K. S. (2017) · The American Journal of Sports Medicine · doi:10.1177/0363546517716641 · Cited by 240
Baron, F., Lechanteur, C., Willems, E., Bruck, F., Baudoux, E., Seidel, L., Vanbellinghen, J.-F., Hafraoui, K., Lejeune, M., Gothot, A., et al. (2010) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2010.01.011 · Cited by 229
Butler, J., Epstein, S. E., Greene, S. J., Quyyumi, A. A., Sikora, S., Kim, R. J., Anderson, A. S., Wilcox, J. E., Tankovich, N. I., Lipinski, M. J., et al. (2017) · Circulation Research · doi:10.1161/circresaha.116.309717 · Cited by 179
Cellular Encapsulation Enhances Cardiac Repair
Levit, R. D., Landázuri, N., Phelps, E. A., Brown, M. E., García, A. J., Davis, M. E., Joseph, G., Long, R., Safley, S. A., Suever, J. D., et al. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000367 · Cited by 174
Oliveri, R. S., Bello, S., & Biering‐Sørensen, F. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.10.014 · Cited by 169
Packham, D. K., Fraser, I. R., Kerr, P. G., & Segal, K. R. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.09.011 · Cited by 167
Matthay, M. A., Pati, S., & Lee, J.-W. (2017) · Stem Cells · doi:10.1002/stem.2551 · Cited by 166
Challenges for mesenchymal stromal cell therapies
Martin, I., Galipeau, J., Kessler, C., Le Blanc, K., & Dazzi, F. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aat2189 · Cited by 163
The Global Landscape of Stem Cell Clinical Trials
Li, M., Atkins, H. L., & Bubela, T. M. (2013) · Regenerative Medicine · doi:10.2217/rme.13.80 · Cited by 154
Hur, J. W., Cho, T.-H., Park, D., Lee, J.-B., Park, J. Y., & Chung, Y.-G. (2015) · Journal of Spinal Cord Medicine · doi:10.1179/2045772315y.0000000048 · Cited by 151
Viswanathan, S., Keating, A., Deans, R., Hematti, P., Prockop, D. J., Stroncek, D. F., Stacey, G., Weiss, D. J., Mason, C., & Rao, M. S. (2014) · Stem Cells and Development · doi:10.1089/scd.2013.0591 · Cited by 137
Application of cell encapsulation for controlled delivery of biological therapeutics
Orive, G., Santos‐Vizcaíno, E., Pedraz, J. L., & Hernández, R. M. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.07.009 · Cited by 136
Skyler, J. S., Fonseca, V. A., Segal, K. R., & Rosenstock, J. (2015) · Diabetes Care · doi:10.2337/dc14-2830 · Cited by 129
Thirumala, S., Gimble, J. M., & Devireddy, R. V. (2009) · Stem Cells and Development · doi:10.1089/scd.2009.0173 · Cited by 116
Allogeneic Human Mesenchymal Stem Cell Infusions for Aging Frailty
Golpanian, S., DiFede, D. L., Khan, A., Schulman, I. H., Landin, A. M., Tompkins, B. A., Heldman, A. W., Miki, R. A., Goldstein, B. J., Mushtaq, M., et al. (2017) · The Journals of Gerontology Series A · doi:10.1093/gerona/glx056 · Cited by 109
Safety and efficacy of mesenchymal stromal cell therapy in autoimmune disorders
Bernardo, M. E., & Fibbe, W. E. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06667.x · Cited by 105
Mesenchymal stem cells as a therapeutic tool to treat sepsis
Lombardo, E., van der Poll, T., DelaRosa, O., & Dalemans, W. (2015) · World Journal of Stem Cells · doi:10.4252/wjsc.v7.i2.368 · Cited by 103
Enhancing the efficacy of mesenchymal stem cell therapy
Mastri, M., Lin, H., & Lee, T. (2014) · World Journal of Stem Cells · doi:10.4252/wjsc.v6.i2.82 · Cited by 102
Immunomodulation by Mesenchymal Stromal Cells and Their Clinical Applications
Rilo, H., Cagliani, J. A., Grande, D. A., Molmenti, E. P., & Miller, E. J. (2017) · Journal of Stem Cell and Regenerative Biology · doi:10.15436/2471-0598.17.022 · Cited by 102
Veronesi, F., Maglio, M., Tschon, M., Aldini, N. N., & Fini, M. (2013) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.34896 · Cited by 94
Olsen, T. R., Ng, K. S., Lock, L. T., Ahsan, T., & Rowley, J. A. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00178 · Cited by 85
Encapsulated mesenchymal stromal cells for in vivo transplantation
Barminko, J., Kim, J. H., Otsuka, S., Gray, A., Schloss, R. S., Grumet, M., & Yarmush, M. L. (2011) · Biotechnology and Bioengineering · doi:10.1002/bit.23233 · Cited by 83
Self-citationStem cells as promising therapeutic options for neurological disorders
Yoo, J., Kim, H., & Hwang, D. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24427 · Cited by 79
Gronthos, S., McCarty, R. C., Mrozik, K. M., Fitter, S., Paton, S., Menicanin, D., Itescu, S., Bartold, P. M., Xian, C. J., & Zannettino, A. C. W. (2009) · Stem Cells and Development · doi:10.1089/scd.2008.0400 · Cited by 75
Human Placenta-derived Cells (PDA-001) for the Treatment of Moderate-to-severe Crohnʼs Disease
MELMED, G. Y., Pandak, W. M., Casey, K. J., Abraham, B. P., Valentine, J. F., Schwartz, D. A., Awais, D., Bassan, I., Lichtiger, S., Sands, B. E., et al. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000441 · Cited by 69
Winkler, T., Perka, C., von Roth, P., Agres, A. N., Plage, H., Preininger, B., Pumberger, M., Geißler, S., Hagai, E. L., Ofir, R., et al. (2018) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12316 · Cited by 67
Landázuri, N., Levit, R. D., Joseph, G., Ortega‐Legaspi, J. M., Flores, C. A., Weiss, D., Sambanis, A., Weber, C. J., Safley, S. A., & Taylor, W. R. (2012) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.1680 · Cited by 63
Zhang, H., Liang, J., Tang, X., Wang, D., Feng, X., Wang, F., Hua, B., Wang, H., & Sun, L. (2017) · Arthritis Research & Therapy · doi:10.1186/s13075-017-1373-2 · Cited by 55
Septic shock: desperately seeking treatment
Huet, O., & Chin-Dusting, J. P. F. (2013) · Clinical Science · doi:10.1042/cs20120668 · Cited by 53
Challenges in animal modelling of mesenchymal stromal cell therapy for inflammatory bowel disease
Chinnadurai, R., Ng, S., Velu, V., & Galipeau, J. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i16.4779 · Cited by 49
Heile, A., & Brinker, T. (2011) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2011.13.2/aheile · Cited by 48
The promise of mesenchymal stem cell therapy for acute respiratory distress syndrome
Antebi, B., Mohammadipoor, A., Batchinsky, A. I., & Cancio, L. C. (2017) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000001713 · Cited by 43
Multipotent adult progenitor cells for hypoxic-ischemic injury in the preterm brain
Jellema, R. K., Ophelders, D. R. M. G., Zwanenburg, A., Nikiforou, M., Delhaas, T., Andriessen, P., Mays, R. W., Deans, R., Germeraad, W. T. V., Wolfs, T. G. A. M., et al. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0459-5 · Cited by 41
Byun, J. S., Kwak, B. K., Kim, T. Y., Jung, J., Ha, B. C., & Park, S. (2013) · Journal of Korean Neurosurgical Society · doi:10.3340/jkns.2013.54.6.467 · Cited by 32
Gray, A., Maguire, T. J., Schloss, R. S., & Yarmush, M. L. (2015) · Biotechnology Progress · doi:10.1002/btpr.2103 · Cited by 23
Reger, R. L., & Prockop, D. J. (2014) · Stem Cells Translational Medicine · doi:10.5966/sctm.2013-0203 · Cited by 18
Kumar, S., Babiarz, J. P., Basak, S., Kim, J. H., Barminko, J., Gray, A., Mendapara, P., Schloss, R. S., Yarmush, M. L., & Grumet, M. (2015) · Nano LIFE · doi:10.1142/s179398441550004x · Cited by 12
Self-citation
Cited by
Bloor, A. J. C., Patel, A., Griffin, J. E., Gilleece, M. H., Radia, R., Yeung, D. T., Drier, D., Larson, L. S., Uenishi, G. I., Hei, D., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1050-x · Cited by 284
Zhuang, W.-Z., Lin, Y.-H., Su, L.-J., Wu, M.-S., Jeng, H.-Y., Chang, H.-C., Huang, Y.-H., & Ling, T.-Y. (2021) · Journal of Biomedical Science · doi:10.1186/s12929-021-00725-7 · Cited by 258
Wang, L. L., Janes, M. E., Kumbhojkar, N., Kapate, N., Clegg, J. R., Prakash, S., Heavey, M. K., Zhao, Z., Anselmo, A. C., & Mitragotri, S. (2021) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10214 · Cited by 162
Progress and Challenges in Targeted Protein Degradation for Neurodegenerative Disease Therapy
Fang, Y., Wang, J., Zhao, M., Zheng, Q., Ren, C., Wang, Y., & Zhang, J. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00844 · Cited by 100
Stem cell-based therapy for pulmonary fibrosis
Cheng, W., Zeng, Y., & Wang, D. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-03181-8 · Cited by 65
Metadata
- Authors
- Kabat, M., Bobkov, I., Kumar, S., & Grumet, M.
- Venue
- Stem Cells Translational Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-12-05
- Volume
- 9
- Issue
- 1
- Pages
- 17-27
- ISSN
- 2157-6564 (ISSN-L)
- 2157-6580
- OpenAlex
- W2992079273
- Cited by
- 444
- References
- 58
- FWCI
- 29.75
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.